Alterity Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Alterity Therapeutics Stock Summary

Alterity Therapeutics competes with Anebulo Pharmaceuticals, Pmv Pharmaceuticals, AN2 Therapeutics, HCW Biologics, and Protara Therapeutics. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimers disease, Huntington disease, Parkinsons disease, and other neurological disorders in Australia. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia. Alterity Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.

Alterity Therapeutics Key Financial Ratios

Alterity Therapeutics Key Balance Sheet Accounts

Alterity Therapeutics Key Income Statement Accounts

Alterity Therapeutics Key Cash Accounts

Alterity Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alterity Therapeutics's current stock value. Our valuation model uses many indicators to compare Alterity Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alterity Therapeutics competition to find correlations between indicators driving Alterity Therapeutics's intrinsic value. More Info.Alterity Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At present, Alterity Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Alterity Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Alterity Therapeutics Systematic Risk

Today, most investors in Alterity Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alterity Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Alterity Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Alterity Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Alterity Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Alterity Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Alterity Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Alterity Therapeutics's daily price indicators and compare them against related drivers.

When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.